Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TRY FIRST: A 12-Week, Randomized, Open-Label Trial of Duloxetine Versus Generic SSRIs in the Treatment of a Severe Depressive Episode

NCT00666757 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00666757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00666757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TRY FIRST: A 12-Week, Randomized, Open-Label Trial of Duloxetine Versus Generic SSRIs in the Treatment of a Severe Depressive Episode
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2008
Completion date
March 31, 2009
Enrollment
750 (actual)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

depression